Is Coherus Oncology, Inc. (CHRS) a Buy, Sell, or Hold?
NASDAQ : CHRS
Coherus Oncology, Inc. — Competitors
$1.41 USD
-$0.06 (-4.08%)
- Volume
- 436.92K
- Average Volume
- 1.04M
- Market Capitalization
- $172.6M
- P/E Ratio
- -1.10
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $2.62
- Year Low
- $0.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.56
CHRS vs. The Competition
| Properties | CHRS | AVTX | CCCC | CDXS |
|---|---|---|---|---|
| Market Cap | $172.6M | $206.12M | $384.77M | $127.19M |
| Shares Outstanding | $122.41M | $11.29M | $110.57M | $90.85M |
| P/E Ratio | -1.1 | -3.13 | -2.92 | -3.83 |
| EPS | -1.11 | -4.21 | -0.82 | -0.35 |
| Day Low | 1.4 | 18.24 | 3.45 | 1.38 |
| Day High | 1.48 | 19.73 | 3.66 | 1.496 |
| Year Low | 0.81 | 7.87 | 1.69 | 0.96 |
| Year High | 2.616 | 24.27 | 5.17 | 3.87 |
| Average Price 50 | 1.4835 | 17.0084 | 3.912 | 2.3272 |
| Average Price 200 | 1.59953 | 16.52147 | 2.85795 | 1.97335 |
| Volume | 436.92K | 885.9K | 1.95M | 1.12M |
| Average Volume | - | - | - | - |